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Astrocytic miR-324-5p is essential for
synaptic formation by suppressing the
secretion of CCL5 from astrocytes
Chenxi Sun1, Liang Zhu1, Rongjie Ma1, Jie Ren1, Jian Wang1, Shane Gao1, Danjing Yang1, Ke Ning2, Bin Ling3, Bing Lu1,
Xu Chen4 and Jun Xu1
Abstract
There is accumulating evidence that astrocytes play an important role in synaptic formation, plasticity, and pruning.
Dicer and the ﬁne-tuning of microRNA (miRNA) network are important for maintaining the normal functions of central
nervous system and dysregulation of miRNAs is implicated in neurological disorders. However, little is known about the
role of Dicer and miRNAs of astrocytes in the homeostasis of synapse as well as its plasticity. By selectively deleting Dicer
in postnatal astrocytes, Dicer-deﬁcient mice exhibited reactive astrogliosis and deﬁcits in dendritic spine formation.
Astrocyte-conditioned medium (ACM) collected from Dicer-null astrocytes caused synapse degeneration in cultured
primary neurons. The expression of chemokine ligand 5 (CCL5) elevated in Dicer-deleted astrocytes which led to the
signiﬁcant augmentation of secreted CCL5 in ACM. In neurons treated with Dicer KO-ACM, CCL5 supplementation
inhibited MAPK/CREB signaling pathway and exacerbated the synaptic formation deﬁciency, while CCL5 knockdown
partially rescued the synapse degeneration. Moreover, we validated CCL5 as miR-324-5p targeted gene. ACM collected
from miR-324-5p antagomir-transfected astrocytes mimicked the effect of CCL5 treatment on inhibiting synapse
formation and MAPK/CREB signaling in Dicer KO-ACM-cocultured neurons. Furthermore, decreased miR-324-5p
expression and elevated CCL5 expression were observed in the brain of aging mice. Our work reveals the non-cell-
autonomous roles of astroglial miRNAs in regulation of astrocytic secretory milieu and neuronal synaptogenesis,
implicating the loss or misregulation of astroglial miRNA network may contribute to neuroinﬂammation,
neurodegeneration, and aging.
Introduction
Neuroinﬂammatory changes, including glial activation
and subsequent production of inﬂammatory cytokines, are
observed in neurodegenerative diseases and normal aging1.
Despite well-established commonalities, reactive astro-
gliosis is a highly heterogeneous state in which astrocyte
activities are regulated in a context-speciﬁc manner by
different molecular signals2. Because astrocytes also
respond to all forms of central nervous system (CNS)
injury or disease, there is growing interest in how reactive
astrogliosis might alter astrocyte functions and thereby
affect neural functions. Meanwhile, over the recent years,
multiple studies have demonstrated that astrocytes have
profound impact on the formation, maturation, function,
and elimination of synapses through various secreted and
contact-mediated signals3. Glial modulation of synapse
function and number is emerging as a critical component
of the role glia play in the process of neurodegeneration4.
Therefore, the role of glia in the process of developing
synapse dysfunction and/or synaptic degeneration is clearly
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a key and potentially targetable component of pathogenesis
in aging and neurodegeneration.
Accumulating evidence indicates that miRNAs are
essential for establishing appropriate synapse number and
spine morphology5. Indeed, altered neural miRNA
expression proﬁles were displayed in intellectual disability
syndromes such as fragile X syndrome, Rett syndrome,
and Down syndrome, and in neurodegenerative diseases
such as Alzheimer’s disease (AD) and Parkinson’s dis-
ease6–9. Besides, miRNAs with important functions in
synaptic and other homeostatic processes are differen-
tially regulated in the ageing human brain10. Neuronal
Dicer ablation demonstrated that a functional neuronal
miRNA system is absolutely crucial for both the correct
development of the nervous system as a whole and for the
differentiation, proper function, and survival of individual
neurons11. Moreover, miR-132 inhibition in primary
cortical and hippocampal neurons in vitro leads to the
activation of PTEN and induces neuronal death12.
Although increasing studies have implicated astrocytes
have a pivotal role in synapse formation and function, still
little is known about the astroglial miRNAs in the reg-
ulation of synaptic development, and the potential effects
of astroglial miRNAs dysfunction in the pathophysiology
of aging, neurodevelopmental disorders, and neurode-
generative disorders.
In this study, we employed a GFAP-Cre-mediated Dicer
conditional deletion mouse model to explore the impact of
miRNAs dysfunction on astroglial inﬂammatory response
and neuronal synapse formation. Our results show that
astrogilal Dicer deletion induces deﬁcits in spine formation
and maturation in cortical and hippocampal neurons;
neurons cocultured with Dicer-null ACM exhibited
decreased synapse density. Reactive astrogliosis was found
in the brain of Dicer-deleted mice; elevated secretion of
GM-CSF, CCL3, CCL4, CCL5, and CXCL1 were detected
in Dicer-null astrocytes. In addition, we validate Ccl5
expression is regulated by miR-324-5p. CCL5 knockdown
alleviated the synapse loss in neurons cocultured with Dicer
KO-ACM. Besides, CCL5 supplementation inhibited the
MAPK/CREB signaling pathway and exacerbated the
synapse degeneration in Dicer KO-ACM-treated neuron.
Furthermore, decreased miR-324-5p expression and ele-
vated Ccl5 expression were discovered in the brain of aging
mice, suggesting the miR-324-5p–Ccl5 axis may contribute
to the synapse loss during aging.
Results
Generation of mGFAP-Cre;Dicerﬂox/ﬂox mice for conditional
Dicer knockout in astrocytes
Glial ﬁbrillary acidic protein (GFAP) is the commonly
used marker for astrocyte, and its expression increased in
the activated astroglia13. To gain a better understanding of
the function of astroglial Dicer and miRNAs in the synapse
formation of developing mammalian brain, we ablated
Dicer1 gene under the promoter of mouse GFAP via the
Cre–loxP genetic system (Fig. 1a). The Cre-mediated
recombination occurs early in postnatal astrocytes
throughout the CNS, but after the occurrence of astro-
gliogenesis14,15. Western blot was performed to conﬁrm the
efﬁciency of Dicer knockout. In Dicer KO astrocytes, the
content of DICER1 reduced to ~13.3% compared with WT
astrocytes (Fig. 1b, c). These data therefore conﬁrmed the
effective Cre-mediated Dicer knockout in astrocytes.
As shown in the Kaplan–Meier curve (Fig. 1d), inac-
tivation of astroglial Dicer resulted in the premature
death occurred as early as P38. mGFAP-Cre;Dicerﬂox/ﬂox
mice were normal at birth and born with normal Men-
delian ratios14, but most of the mice died around P50.
Loss of astroglial Dicer had no variation on the gross
brain morphology and brain size in P21 and P42
(Fig. 1e). Coronal sections demonstrated that mGFAP-
Cre;Dicerﬂox/ﬂox mice have structurally normal cellular
layers in the cortex and hippocampus (data not shown).
Neuronal progenitor cells express GFAP and potentially
differentiate into neurons and astrocytes. Therefore, we
examined if the recombination occurs correctly by ana-
lyzing a reporter line, mGFAP-Cre;Rosa26-EGFP (Fig. 1f).
The co-stain of EGFP and NeuN labeled the incorrectly
Cre-expressing neurons in the cortex and hippocampus
(Fig. 1g–i). Cre-expressing neurons (EGFP+NeuN+ cells)
were less than 4.1% of cortical neurons and 17.2% of
hippocampal neurons before P42. At P60, however, Cre-
expressing neurons increased signiﬁcantly to 12.3% of
cortical neurons and 33.2% of hippocampal neurons.
Reactive astrogliosis and synapse degeneration in
astroglial Dicer-knockout mice
By immunostaining GFAP, we detected astroglial acti-
vation at P21 and P42 in Dicer KO mice (Fig. 2a–c). As
depicted in Fig. 2a, the GFAP-stained main cellular pro-
cesses of astrocyte form bushy-like structure with bran-
ches evenly stretching to different directions in lateral
septal nucleus (LSN) region of WT mice, while the main
processes get thicker and displayed an unarranged
structure in LSN astrocytes of Dicer-null mice. Besides,
the GFAP-positive cell ratio increased to 44.0% in this
region of Dicer-deﬁcient mice compared with 28.5% in
WT mice (Fig. 2b). Enhanced GFAP staining was also
found in the cortex of Dicer KO mice. GFAP-positive
astrocytes increased to 16.3% in total cortical cells of
Dicer mutant mice, compared with 3.6% in WT cortical
cells (Fig. 2c). Considering reactive astrogliosis is char-
acterized by astrocytic hypertrophy and increased GFAP
expression, these results indicating the dramatic reactive
astrogliosis are caused by astrocytic Dicer deletion.
Presynaptic marker synapsein1 (SYN1) was immunos-
tained in brain sections of Dicer mutant mice and WT
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littemates to determine synaptic density (Fig. 2d–f). SYN1
puncta number reduced to 88.5% in the cortex of Dicer
KO mice compared to the WT control. While in the
hippocampi, SYN1 puncta number reduced to 79.1%. This
result revealed the severe neuronal synapse loss following
astroglial Dicer deletion.
Reduced mature spines in the cortex and hippocampus of
astroglial Dicer KO mice
Golgi staining was implied to reveal changes in spine
density and spine morphology in Dicer KO mice. Spine
densities were quantiﬁed in apical dendrite and basal
dendrite separately in cortical and hippocampal pyramidal
Fig. 1 Generation and characterization of conditional astrocytic Dicer-knockout mice. a A schematic of crossing mGFAP-Cre transgenic mice
with Dicerloxp/loxp mice to generate mGFAP-Cre;Dicerﬂox/ﬂox mice. b, c Westen blot analysis conﬁrmed the deletion of DICER1 in Dicer KO astrocytes.
Student’s t-test, ∗∗∗P < 0.001. d The Kaplan–Meier survival curves of Dicer mutant and WT mice. Median survival days are P50 (n= 17). e Brains of Dicer
mutant mice shows similar gross morphology with their wild-type littermates. Scale bar= 1 cm. f A schematic of lineage tracing using mGFAP-Cre
transgenic mice crossing with ROSA26-EGFP reporter line. g Distribution of EGFP+NeuN+ cells in the cortex and hippocampus of the mGFAP-Cre;
ROSA26-EGFP reporter mouse at postnatal stages. Scale bar= 100 μm. h, i Quantiﬁcation of EGFP+NeuN+ cell ratios in total NeuN+ cells in cortex (h)
and hippocampus i at postnatal stages (n= 6). One-way ANOVA, ∗∗∗P < 0.001
Sun et al. Cell Death and Disease          (2019) 10:141 Page 3 of 16   141 
Ofﬁcial journal of the Cell Death Differentiation Association
neurons (Fig. 3). Mushroom spines represent the mature
spines which have larger, more complex postsynaptic
density, and functionally stronger in response to gluta-
mate16. While thin spines and stubby spines represent the
immature spines which are ﬂexible, rapidly enlarging or
shrinking in brain development17.
In cortical neurons of Dicer-null mice, total spine densities
reduced signiﬁcantly in apical dendrite at P21, and reduced
in basal dendrite at P21 and P42 (Fig. 3b, c). Among the three
spine types, mushroom spine densities decreased dramati-
cally at P21 and P42 in both apical dendrites and basal
dendrites. Besides, thin spine density showed ~2.8-fold
increase in the basal dendrite at P21 (Fig. 3d, e).
In the hippocampal neurons of mGFAP-Cre;Dicerﬂox/ﬂox
mice, signiﬁcant decreases in total spine densities were
observed in both apical and basal dendrite at P21 and P42
(Fig. 3f, g). Furthermore, mushroom spine densities
reduced signiﬁcantly at P21 and P42 in apical dendrites
and basal dendrites in the hippocampi of Dicer-null mice.
A ~1.9-fold increase in thin spines was detected in apical
dendrites at P21. Moreover, upregulated stubby spine
densities were found in apical dendrite at P42, in basal
dendrite at P21 and P42 (Fig. 3h, i).
Taken together, the compromised miRNA regulation in
astrocyte led to synapse degeneration, reduced mature spines
and increased immature spines in cortex and hippocampus,
Fig. 2 Astrocytic Dicer KO led to reactive astrogliosis and synapse loss in different brain area. a Increased GFAP-positive cells in the LSN at P21
and in the primary somatosensory cortex at P42 in Dicer mutant mice. Scale bar= 250 μm. b, c Quantiﬁcation of GFAP-positive cell percentage in the
LSN (b) and cortex (c) of Dicer mutant and WT mice. d Decreased synaptic puncta in the cortex and hippocampus of Dicer-deﬁcient mice at P21.
Scale bar= 25 μm. e, f Quantiﬁcation of SYN1 puncta in the cortex (e) and hippocampus (f) of Dicer-deﬁcient and WT mice. Student’s t-test,
∗∗P < 0.01, ∗∗∗P < 0.001
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implied the miRNAs in astrocyte participate an important
part in spine formation and/or maturation in vivo.
Elevated secretion of inﬂammation factors in mGFAP-Cre;
Dicerﬂox/ﬂox astrocyte
In accordance with the hypertrophy GFAP immunos-
tained astrocyte structure in vivo (Fig. 2a), cytoskeleton
structure of cultured Dicer mutant astrocytes also displayed
dramatic variation (Fig. 4a). Moreover, Dicer KO astrocytes
proliferated more rapidly than WT astrocytes at ﬁrst and
second passage, but exhibited more degeneration starting
from the second passage (data not shown). Thus, Dicer
deletion causes dramatic impacts on the cytoskeleton
arrangement, proliferation, and survival of astrocytes.
Astrocyte-conditioned medium (ACM) has profound
enhancement effect to the synapse formation and elec-
trophysiology of cultured retinal ganglion cells18. Primary
hippocampal neurons were cocultured with Dicer KO-
ACM or WT-ACM for 48 h (DIV8-DIV10). Neurons
cocultured with Dicer KO-ACM exhibited a signiﬁcant
decrease in synaptic density compared with neurons
cocultured with WT-ACM (Figure 4c; 70.6% ± 4.5% of
WT-ACM).
Golgi staining revealed the synapse degeneration in Dicer
KO mice (Fig. 3); besides, the synapse loss could be reca-
pitulated in neurons cocultured with Dicer KO-ACM.
Thus, extracellular molecules in Dicer KO-ACM probably
play pivotal roles leading to synaptic degeneration. Reactive
Fig. 3 Ablation of astrocytic Dicer led to decreased spine density in cortical neurons and hippocampal neurons. a Schematic overview of
standard categories of dendritic protrusions used for analysis of spine densities. Mushroom spines marked by white arrows, stubby spines marked by
black arrows, and ﬁlopodial-like thin spines marked by asterisk. b Example of second-order branches of basal dendrites arising from Golgi-
impregnated pyramidal neurons in the somatosensory cortex from WT and Dicer mutant mice. Scale bar= 25 μm. c Quantiﬁcation of the total spine
density in cortical neurons of Dicer mutant and WT mice at P21 and P42. d, e The percentage of mature mushroom, thin and stubby-type spines in
cortical apical dendritic spines (d) and in cortical basal dendritic spines (e). f Example of second-order branches of apical dendrites arising from Golgi-
impregnated pyramidal neurons in the CA1 hippocampal region from WT and Dicer mutant mice. Scale bar= 25 μm. g Quantiﬁcation of the total
spine density in hippocampal neurons of Dicer mutant and WT mice at P21 and P42. h, i The percentage of mature mushroom, thin and stubby-type
spines in CA1 pyramidal apical spines (h) and in CA1 pyramidal basal spines (i). Statistical signiﬁcance was determined by Student’s t-test, where ∗P <
0.05, ∗∗P < 0.01, ∗∗∗P < 0.001
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astrocytes can release a wide variety of secretory factors,
including inﬂammatory modulators, chemokines, and
cytokines. These factors can be either neuroprotective (such
as interleukin-6 (IL-6) and transforming growth factor-β)
or neurotoxic (such as IL-1β and tumor necrosis factor-α
(TNF-α))19,20. Considering reactive astrogliosis was
observed in Dicer KO mice (Fig. 2a), we proﬁled the
expression of inﬂammatory factors in Dicer KO astrocytes
and explored their potentials roles in synapse regulation.
Forty cytokines proteome proﬁler (R&D, ARY006) was
introduced to study the relative content of inﬂammatory
factors in Dicer KO-ACM. The pixel density of each
detection point represented the concentration of individual
inﬂammatory factor (Fig. 4e). Coordinates and targets of the
cytokine array were indicated in Supplementary S1.
The concentration of GM-CSF (CSF3), IL-1ra, IL-6,
IL-7, IL-10, IL-27, IP-10 (CXCL10), KC (CXCL1), MCP-5
(CCL12), MIG (CXCL9), MIP-1α (CCL3), MIP-1β
(CCL4), MIP-2 (CXCL2), RANTES (CCL5), SDF-1
(CXCL12), and TREM-1 elevated signiﬁcantly, while the
concentration of IL-1α and TNF-α decreased in Dicer
KO-ACM compared with WT-ACM control (Fig. 4f, g).
Luminex analysis was employed to validate the variations
of these cytokines (Fig. 4h; Supplementary S2). Increased
secretion of CCL3, CCL4, CCL5, CXCL1, and GM-CSF
were conﬁrmed by both proteome proﬁler and Luminex
analysis (Fig. 4g, h).
Gene expression comparison of Ccl3, Ccl4, Ccl5, and
Cxcl1 were analyzed by quantitative reverse transcriptase
polymerase chain reaction (qRT-PCR). Ccl3, Ccl4, and
Cxcl1 exhibit similar level between these astrocytes, while
Ccl5 expression exhibits ~6.7-fold increase in Dicer mutant
astrocyte (Fig. 4i). These data therefore suggest speciﬁc
miRNA(s) participate(s) in the post-transcriptionally reg-
ulation of Ccl5 expression in astrocyte.
CCL5 reduces synapse number in neurons conditioned by
Dicer KO-ACM
We next explored the effect of CCL5 on synaptic for-
mation. About 0.3 μg/ml CCL5 antibody was used to
inhibit CCL5 level in WT-ACM and Dicer KO-ACM, and
neutralization effect was conﬁrmed by enzyme-linked
immunosorbent assay (ELISA) (Fig. 5a). Besides, ELISA
results showed ~3.0-fold increase of CCL5 concentration
in Dicer KO-ACM, and further conﬁrmed the elevated
CCL5 expression after astroglial Dicer knockout.
Inhibiting CCL5 level in Dicer KO-ACM induced ~1.2-
fold increased synapse density in cocultured neurons
compared to Dicer KO-ACM alone, but not reaching the
same level as in neurons cocultured with CCL5 neutralized
WT-ACM. No signiﬁcant variation in synapse density was
observed in neurons cultured with neutralized WT-ACM
compared with the WT-ACM cultured controls (Fig. 5b, c).
On the other side, supplementing recombinant CCL5
protein (ﬁnal concentration 100 ng/ml) aggravated the
synapse decrease in Dicer KO-ACM-conditioned neurons
(84.3% ± 5.4% compared to Dicer KO-ACM alone). How-
ever, in contrast to neurons cocultured with WT-ACM, no
obvious difference in synaptic density was detected after
supplemented CCL5 in WT-ACM. Overall, CCL5 induced
synapse loss in the secretion milieu of Dicer KO astrocyte,
but not in WT controls. Therefore, the varied secretory
factor(s) in the Dicer KO astrocytic secretory milieu
(probably other elevated inﬂammatory factors) might work
in corporation with CCL5 in the inhibition of
synaptogenesis.
CCL5 inhibits MAPK and CREB signaling in neurons
conditioned with Dicer KO-ACM
We explored how the signaling in neurons altered after
Dicer KO-ACM and CCL5 treatment. DIV12 primary
neurons were treated with Dicer KO-ACM or WT-ACM
for 1 h. Neurons cultured with Dicer KO-ACM showed
decreased phospho-ERK1/2 levels and phospho-CREB
levels compared with neurons treated with WT-ACM
(Fig. 5d–g).
Mitogen-activated protein kinase p44/42 (MAPKs, or
ERK1/2) and cAMP-responsive element-binding protein
(CREB) have been implicated in cortical plasticity and
hippocampal learning and memory21,22. We next detected
whether CCL5 supplement affects MAPK and CREB sig-
naling in neurons. DIV10 primary neurons were
(see ﬁgure on previous page)
Fig. 4 CCL5/RANTES expression increased in Dicer-null astrocytes. a Phase-contrast and GFAP immunoﬂuorescence images of Dicer mutant
astrocytes and WT astrocytes at ﬁrst passage. BF Bright ﬁeld. b Flowchart showing the collection of ACM, and the treatment of neurons with ACM. c,
d Immunostainging of pCAG-YFP plasmid-transfected neurons (green) with presynaptic SYN1 (red) shows few synapses formed in neurons
cocultured with Dicer KO-ACM compared with neurons cocultured with WT-ACM. n= 9. Scale bar= 50 μm. e, f The cytokines proteome proﬁler
revealed differential expression of inﬂammatory factors in ACM collected from WT or Dicer-null astrocyte. Arrows indicates the position of CCL5/
RANTES detection points. Quantization of inﬂammatory factor levels from the membranes are shown in f. Data were normalized with the internal
positive control on the same membrane and are presented as mean of three independent determinations. ∗P < 0.05, compared with WT-ACM. g
Proteome proﬁler revealed elevated CCL3, CCL4, CCL5, CXCL1, and GM-CSF in Dicer KO-ACM. h Luminex revealed elevated CCL3, CCL4, CCL5, CXCL1,
and GM-CSF in Dicer KO-ACM. i The expression of Ccl3, Ccl4, Ccl5, and Cxcl1 was analyzed and compared by qRT-PCR in primary cortical astrocytes
from WT and Dicer KO mice. GAPDH was used as a reference gene. Student’s t-test, ∗∗P < 0.01
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cocultured with WT-ACM or Dicer KO-ACM for 2 days;
100 ng/ml CCL5 protein was added directly into the
medium. Compared with neurons conditioned by WT-
ACM, decreased phospho-ERK1/2 levels and phospho-
CREB levels were detected after 10 and 30min of CCL5
treatment in Dicer KO-ACM-conditioned neurons
(Fig. 5h–k). Maraviroc is a selective CCR5 antagonist23.
Pretreatment of Maraviroc for 30min abolished the
changes in the phospho-ERK1/2 level and the phospho-
CREB level after CCL5 treatment at 30 min, indicating
CCR5 is the neuronal receptor of CCL5 involving MAPK
and CREB signaling cascade.
MiR-324-5p regulates the expression of Ccl5
TargetScan and miRanda were employed to identify
the miRNAs targeting Ccl5 gene. Antisense inhibitors of
seven predicted miRNAs (Fig. 6a) and scrambled nega-
tive control were transfected into WT astrocytes.
Medium was collected 24 h after transfection; CCL5
concentration was examined by ELISA. In astrocytes
transfected with mmu-miR-324-5p inhibitor, the secre-
tion of CCL5 increased to ~234.5 pg/ml, while astrocytes
transfected with other inhibitors showed no signiﬁcant
difference (Fig. 6b). Besides, astrocytic CCL5 secretion
after miR-324-5p inhibition is comparable to that of KO
astrocytes. Overexpression of miR-324-5p by transfect-
ing astrocytes with 50 nM miR-324-5p agomir decreased
Ccl5 mRNA levels after 36 h (Fig. 6c). These results
suggested the role of miR-324-5p in mediating Ccl5
regulation.
MiR-324-5p antagomir-transfected ACM induces synapse
degeneration and MAPK/CREB signaling inhibition in Dicer
KO-ACM-conditioned neurons
The increased Ccl5 expression in astrocytes following
miR-324-5p inhibition prompted us to investigate whe-
ther dysregulation of this miRNA involved in the reg-
ulation of synapse plasticity. MiR-324-5p antagomir was
transfected to knockdown miR-324-5p level in astrocyte.
ACM collected from miR-324-5p antagomir-transfected
astrocytes (miR-ACM), or scrambled negative control
antagomir-transfected astrocytes (NC-ACM), was added
to WT-ACM or KO-ACM in a ratio of 1:1. MiR-ACM
further decreased the synaptic number in neurons treated
with KO-ACM, but had no signiﬁcant effect on neurons
treated with WT-ACM (Fig. 6d, e).
After cocultured with WT-ACM or Dicer KO-ACM for
2 days, primary neurons were treated with miR-ACM.
MiR-ACM treatment markedly decreased phospho-
ERK1/2 level and phospho-CREB level at 10 and 30min in
neurons conditioned with Dicer KO-ACM, indicating the
inhibited MAPK/CREB signaling in these neurons
(Fig. 6f–i). Taken together, these data implied knockdown
of astroglial miR-324-5p could mimic the effect of CCL5
treatment on neuronal degeneration and MARK/CREB
signaling in cocultured neurons.
Decreased miR-324-5p and increased Ccl5 expression in
the brain of aging mice
During normal aging, human neocortex displays an
average 20% decrease of presynaptic terminal density24. In
our study, immunostaining revealed SYN1 puncta
decreased to ~70.4% in the cortex of 24-month-old mice,
and decreased to ~58.2% in the hippocampus compared
with 5-month-old control (Fig. 7a–c).
We further evaluated the relative expression levels of
miR-324-5p and Ccl5 mRNA in aging mice. In the cortex,
miR-324-5p expression decreased to 24.7% compared
with younger control. Moreover, miR-324-5p expression
downregulated to 58.5% in the hippocampus of aging
mice (Fig. 7d). QRT-PCR revealed ~1.6-fold increase of
Ccl5 expression in the cortex of aging mice. While in the
hippocampus, Ccl5 expression showed ~1.3-fold increase
compared with the 5-month control (Fig. 7e).
Discussion
Astrocytes respond to all forms of CNS damage and
disease by undergoing cellular, molecular, and functional
changes commonly referred to as reactive astrogliosis25.
The pronounced upregulation of GFAP, hypertrophy of
(see ﬁgure on previous page)
Fig. 5 CCL5 supplement exacerbated the synapse loss induced by Dicer KO-ACM, and inhibited MAPK/CREB signaling in Dicer KO-ACM-
conditioned neurons. a CCL5 neutralization was conﬁrmed by ELISA. b, c Quantiﬁcation the synapse number in neurons treated by WT-ACM, KO-
ACM, WT-ACM supplemented with CCL5 antibody (WT-ACM-CCL5 Ab), KO-ACM supplemented with CCL5 antibody (KO-ACM-CCL5 Ab), WT-ACM
supplemented with 100 ng/ml CCL5 (WT-ACM+ CCL5), and KO-ACM supplemented with 100 ng/ml CCL5 (KO-ACM+ CCL5). n= 25. Scale bar=
50 μm. d, e Dicer KO-ACM reduced p-ERK1/2 (normalized with total ERK1/2) in primary cultured neurons. f, g Dicer KO-ACM reduced p-CREB
(normalized with total CREB) in primary cultured neurons. h, i Compared with WT-ACM-conditioned controls, Dicer KO-ACM-conditioned neurons
showed reduced levels of p-ERK1/2 at 10 and 30min after treatment with 100 ng/ml of CCL5. Pretreatment with Maraviroc blocked the changes in
p-ERK1/2 levels observed at 30 min after CCL5 supplement. j, k Compared with WT-ACM-conditioned controls, Dicer KO-ACM-conditioned neurons
showed reduced p-CREB levels at 10 and 30min after treatment with 100 ng/ml of CCL5. Pretreatment with Maraviroc blocked the variations of
p-CREB levels at 30 min following CCL5 supplement. Error bars are the mean ± SEM. Statistical signiﬁcance was determined by Student’s t-test, where
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001
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Fig. 6 (See legend on next page.)
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(see ﬁgure on previous page)
Fig. 6 ACM collected from miR-324-5p knockdown astrocytes mimicked CCL5 treatment on neuronal synapse plasticity and MAPK/CREB
signaling. a A diagram showing positions and sequences of predicted miRNA target sites in the 3′-UTR of Ccl5 gene. b CCL5 released extracellularly
from WT astrocytes transfected with different miRNA inhibitors was collected after 24 h and detected using ELISA assay (n= 3). c QRT-PCR analysis of
Ccl5 expression in WT astrocytes after transfection with miR-324-5p agomir (n= 3). d, e The miR-ACM exacerbated the synapse loss in neurons
conditioned by Dicer KO-ACM, but had no signiﬁcant effect on WT-ACM-conditioned neurons. Scale bar= 50 μm. e Quantiﬁcation of synapse
number in neurons treated by WT-ACM added with an equal volume of NC-ACM, WT-ACM added with an equal volume of miR-ACM, Dicer KO-ACM
added with NC-ACM, and Dicer KO-ACM added with miR-ACM. n= 15. f, g Treatment of miR-ACM decreased levels of p-ERK1/2 at 10 and 30min in
Dicer KO-ACM-conditioned neurons compared with neurons conditioned by WT-ACM. h, i Treatment of miR-ACM decreased p-CREB levels at 10 and
30min in Dicer KO-ACM-conditioned neurons compared with neurons conditioned by WT-ACM. Statistical signiﬁcance was determined by Student’s
t-test, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001
Fig. 7 Decreased synaptic puncta, decreased expression of miR-324-5p, and increased Ccl5 expression in the brain of aging mice. a
Decreased synaptic puncta in the cortex and hippocampus of aging mice. Scale bar= 25 μm. b, c Quantiﬁcation of SYN1 puncta in cortex (b) and
hippocampus (c) of 5-month-old mice and 24-month-old mice. d Decreased expression of miR-324-5p in the cortex and hippocampus of aging mice
were detected by qRT-PCR. U6 was used as internal control. n= 3. e QRT-PCR revealed elevated Ccl5 mRNA level in the hippocampus of aging mice.
n= 3. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 by Student’s t-test
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cell body and processes indicated the severe reactive
astrogliosis in LSN and cortex in Dicer-null mice, implied
the pivotal role of astroglial miRNAs in the regulation of
astrocyte activation.
Glial cell activation induced by injury, ischemia, or
neurodegeneration is also thought to greatly alter the
behavior of glial cells toward neuronal synapses, sug-
gesting that neuroinﬂammation potentially contributes
to synapse loss primarily mediated by altered glial
functions4. The current evidence implicating synapse
loss in neurodegenerative disease etiology is over-
whelming, but the role of astroglia in the process of
synaptic degeneration has only recently been considered
in earnest. The spatio-temporal activation of astrocytes
was also reported to correlate with pathological neu-
roinﬂammatory responses and neurodegenerative
events26,27. Furthermore, the capacity to secrete immu-
nologically relevant cytokines and chemokines poses
astrocytes in the position to play a key role in ﬁne-tuning
the neuroinﬂammatory response.
In addition to the roles in the immune system, che-
mokines are reported to play important roles in brain
development, neurogenesis, and neuroinﬂammation28,29.
However, the effects of most of the chemokines on
synaptic plasticity and neurological disorders remain
largely unknown. Our results revealed miRNAs partici-
pate in the regulation of cytokines and chemokines
release in astrocytes. By employing proteome proﬁler
and Luminex, elevated secretion of CCL3, CCL4, CCL5,
CXCL1, and GM-CSF were found in Dicer-deﬁcient
astrocytes in vitro.
Constitutive expression of CCL5 receptors, namely
CCR1, CCR3, CCR5, have been conﬁrmed in human and
mouse neurons30–32. CCR5 is a seven transmembrane G
protein-coupled receptor known to modulate parallel
signaling cascades implicated in synapse plasticity,
including the inhibition of adenylyl cyclase, and activation
of PI3K/AKT and MAPK singling pathway33–35. ERK1/2
and CREB are known to have a central role in synaptic
plasticity, LTP induction and affect learning and mem-
ory36,37. Decreased CCR5 function results in enhance-
ment in MAPK/CREB signaling, LTP and hippocampus-
dependent memory in Ccr5 knockdown mice, while
overexpression of CCR5 causes learning and memory
deﬁcits38. Treatment with the CCR5 antagonist Maraviroc
has been reported to improve neurocognitive test per-
formance among patients with moderate cognitive
impairment39.
In this study, CCL5–CCR5 axis decreased MAPK/CREB
signaling in neurons conditioned with the imbalanced
cytokines released by Dicer mutant astrocytes suggest the
altered astrocytic secretion milieu following miRNA dys-
function changed the crosstalk between astrocyte and
neuron in long-lasting way (Fig. 8). Although we
illustrated elevated secretion of chemokines and inﬂam-
matory factors in Dicer mutant astrocytes, especially the
increased secretion of GM-CSF, CCL3, CCL4, CCL5, and
CXCL1 were conﬁrmed by Proteome proﬁler and Lumi-
nex, much work remains to be done to identify the spe-
ciﬁc secreted factor(s) that formed the microenvironment
that facilitate the induction of neuronal synapse degen-
eration by CCL5–CCR5 axis.
Increased secretion of GM-CSF in Dicer-deﬁcient
astrocytes suggested miRNAs participated in the reg-
ulation of this factor. Growing body of literature sug-
gests GM-CSF has neuroprotective properties in the
study of Parkinson’s disease40 and stroke41. Although
the gross effect of the Dicer KO astrocytic milieu
inhibits the neuronal synaptic formation, the upregu-
lated GM-CSF in the Dicer-deﬁcient astrocytes might
play a protective counteract role against the synapse
loss and neuronal dysfunction. Deep understanding
Fig. 8 The proposed mechanism of astroglial miR-324-5p and CCL5 in
regulating neuronal synaptogenesis under the inﬂammation
microenvironment induced by Dicer-knockout astrocyte
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of the sophisticated regulation of astroglial secretory
factors beyond the few described above will certainly
contribute to the comprehensive understanding of
astrocyte-to-neuron signaling, and broaden our under-
standing of astrocytes as mediators of responses to CNS
disorders.
Loss of synapses has emerged as a hallmark of several
neurodegenerative diseases, as well as normal aging42. In
mouse models of AD, early decrease in presynaptic
terminal and postsynaptic density before plaque forma-
tion were observed43. Decrease in spine density was
observed in cortical biopsies from early-stage AD
patients44. In this study, dramatic decreased mushroom
spine densities were examined in cortical and hippo-
campal neurons in astrocytic Dicer-deﬁcient mice, indi-
cating the spine degeneration after astroglial miRNA loss
of function. Besides, the imbalanced astrocytic miRNAs
result in synapse loss in cultured neurons through altered
secretory milieu. These data highlight that astroglial
miRNAs participate in synaptic plasticity regulation
in vivo and in vitro. The potential therapeutic roles of
astroglial miRNAs for preventing synaptic loss which
could eventually cause neurodegeneration deserve further
investigation.
Besides the synapse loss, biological aging is character-
ized by a chronic low-grade inﬂammation level. This
chronic phenomenon has been named “inﬂamm-aging”
and is a highly signiﬁcant risk factor for morbidity and
mortality in the older persons45. Indeed, the interaction
between the nervous and immune systems during aging is
an area of avid interest, but many aspects remain
unclear46. In our study, decreased synapse densities were
observed at cortex and hippocampus in the brain of aging
mice. Elevated CCL5 expression and declined miR-324-5p
expression were identiﬁed in these regions of aging brain
compared with the 5-month control. Considering CCL5
could negatively regulate neuronal synapse formation
under the imbalanced astrocytic secretory milieu,
miRNA-mediated CCL5 elevation could be inducer of
synapse degeneration in the pathogenesis of aging. It is
tempting to speculate that though knockdown and knock-
in technics, modulating the expression of astrocytic
miRNAs and cytokines, may be possible future ther-
apeutic targets to alleviate the synaptic defects in the
pathogenesis of aging and neurodegenerative disorders.
Material and methods
Generation of transgenic mice and genotyping
The mGFAP-Cre transgenic mice47 were mated with
Dicerﬂox/ﬂox mice48 to generate mGFAP-Cre;Dicerﬂox/−
mice, which were then mated with Dicerﬂox/ﬂox mice to
generate mGFAP-Cre;Dicerﬂox/ﬂox mice (designated Dicer
KO mice), and their littermates as the WT control. The
mGFAP-Cre mice were crossed with Rosa26-EGFP
mice49 to examine mGFAP-Cre activity. Mice were gen-
otyped by PCR.
Animal maintenance and research approval for this
study has been given by the Ethical Committee of the
Experimental Animal Center afﬁliated with the Medicine
School of Tongji University. All experiments were done
according to institutional ethical guidelines on animal
care.
Cultures of primary astrocyte and preparation of ACM
Cerebral cortices were harvested from 24 h C57BL/6
mice, homogenized by mechanical dissociation, and the
cell suspension was diluted in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 20% fetal bovine
serum (Gibco, Rockford, IL). Dissociated cells from 1 to
2 pups were plated in a 25 cm2 tissue culture ﬂask coated
with 1 mg/ml poly-D-lysine (Sigma-Aldrich, St. Louis,
MO). After 6 days, the ﬂasks were sealed and shaken at
220 rpm for 18 h at 37 °C to remove microglia, oligo-
dendrocyte, and neuron. Adherent cells (astrocytes) were
dissociated with 0.25% trypsin (ThermoFisher Scientiﬁc,
Rockford, IL).
To prepare ACM, KO astrocytes and WT astrocytes in
the ﬁrst passage were plated at the same density onto
10 cm poly-D-lysine coated ﬂask. Conﬂuent cultures of
astrocytes were washed three times in PBS, and fed with
8 ml Neurobasal medium (without B27, or glutamine).
ACM was collected after 3 and 6 days, combined, cen-
trifuged at 1000g for 5 min to remove cell debris, and
stored at −80 °C until further analysis.
Primary neuron cultures and transfection
Primary neuronal culture was described previously50.
Brieﬂy, hippocampi from E16.5 mice were isolated and
dissociated with papain. Hippocampal neurons were pla-
ted onto poly-D-lysine-coated coverslips or six-well dish at
densities of 200–300 cells per mm2 in neuronal plating
medium. When neurons adhered (after 3–4 h), medium
was completely replaced with neuronal maintenance
medium containing Neurobasal medium (Gibco),
B27 supplement (Gibco), and GlutaMax (Gibco). Medium
was half-changed twice a week. Cytosine arabinoside
(Sigma-Aldrich) was added 4 days after plating to limit
glial proliferation.
For yellow ﬂuorescent protein (YFP) expression, 2 μl of
Lipofectamine 2000 (Invitrogen, Rockford, IL) in 100 μl
Opti-MEM (Gibco) was incubated for 5 min, and added
to an equal volume of Opti-MEM containing 1 μg
of pCAG-YFP plasmid. The DNA/Lipofectamine
mix was incubated 30 min at room temperature, and
then added to neuron. After 6–8 h at 37 °C, medium
was half-replaced. Neurons were cultured additional
2 days before ﬁxation and immunocytochemistry for
further analysis.
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Golgi staining
Brains from postnatal day 21 (P21) and P42 WT mice
and KO mice were impregnated in Golgi solutions using
the FD Rapid Golgi staining kit (FD Neurotechnologies,
Columbia, MD) according to the manufacturer’s
instructions. Coronal sections of 150 μm were made on a
cryostat. After staining, images were captured with a ×40
objective on a Leica confocal laser scanning SP5
microscope with bright ﬁeld settings. For spine density
analysis, dendrite segments of 25–150 μm were ran-
domly selected on the secondary apical or basal dendrite.
According to the head diameter and spine length, den-
dritic spines were divided into three categories for
quantiﬁcation: mushroom type, thin type, and stubby
type16.
Immunochemical staining
Brain sections or neurons were ﬁxed in 4% paraf-
ormaldehyde in PBS for 10 min, permeabilized, and
blocked with 3% donkey serum in PBS containing 0.3%
Triton X-100. Then neurons were incubated with pri-
mary antibody at 4 °C overnight, followed by incubation
with appropriate secondary antibody conjugated
to Alexa Fluor (Molecular Probes, Rockford, IL).
Primary antibodies used were mouse antibody to NeuN
(Sigma-Aldrich), rabbit antibody to GFAP (Cell Signal-
ing Technology, Danvers, MA), mouse antibody to
Synapsin1 (SYSY, Goettingen Germany). Nuclei were
counterstained with DAPI (Roche, Indianapolis, IN).
Images were collected on a Leica confocal laser scanning
SP5 microscope.
Detection of CCL5 by ELISA
Levels of CCL5 were determined using mouse CCL5
ELISA Kit (R&D Systems, Minneapolis, MN), following
the manufacturer’s protocol. Brieﬂy, samples or standards
were added to the microplates, CCL5 standard was
measured in duplicates, and samples in triplicates. After
incubated with detection antibody at 4 °C overnight,
microplates were washed extensively, followed by incu-
bation with streptavidin-HRP plus substrate for signal
development. The optical density of each well was
detected using SpectraMax M5 (Molecular Devices, San
Jose, CA). The concentration of CCL5 in each sample was
calculated based on the standard curve prepared in the
same experiment.
RNA puriﬁcation and quantitative-PCR
Total RNA was prepared by directly lysing the cultured
astrocytes in TRIzol (Invitrogen) reagent. Treated with
RNase-free DNase and reverse transcribed the mRNA
into cDNA by RT reagent Kit with gDNA Eraser (Takara,
Shiga, Japan). Real-time qPCR reactions were performed
on ABI 7500 using SYBR Premix Ex Taq (Takara). The
relative gene expression levels were normalized to that of
the housekeeping gene GAPDH. Data were analyzed using
the 2−ΔΔct method51. The sequences of the primers used
were as follows: Ccl3, forward 5′-CAT GAC ACT CTG
CAA CCA AGT CTT C-3′ and reverse 5′-GAG CAA
AGG CTG CTG GTT TCA -3′. Ccl4, forward 5′-GAG
ACC AGC AGT CTT TGC TCC A-3′ and reverse 5′-
GGA GCT GCT CAG TTC AAC TCC A-3′. Ccl5, for-
ward 5′-GGA GTA TTT CTA CAC CAG CAG CAA G-3′
and reverse 5′-GGC TAG GAC TAG AGC AAG CAA
TGA C-3′. Cxcl1, forward 5′-TGC ACC CAA ACC GAA
GTC-3′ and reverse 5′-GTC AGA AGC CAG CGT TCA
CC-3′. GAPDH, forward 5′-GGT GAA GGT CGG TGT
GAA CG-3′ and reverse 5′-CTC GCT CCT GGA AGA
TGG TG-3′.
SDS-PAGE and western blotting
Cellular lysates from cultured neurons were prepared
using RIPA buffer (ThermoFisher Scientiﬁc) supple-
mented with protease inhibitor cocktail and phospha-
tase inhibitor cocktail (ThermoFisher Scientiﬁc). After
measuring protein concentration with the BCA protein
assay kit (Pierce, Rockford, IL), protein samples were
loaded to 10% SDS-polyacrylamide gels. After separa-
tion, proteins were transferred onto polyvinylidene
diﬂoride (PVDF) membranes. The PVDF membranes
were blocked with 5% bovine serum albumin and then
probed with primary antibodies (phospho-ERK1/2,
Abcam, ab76299, 1:5000 dilution; ERK1/2, Abcam,
ab184699, 1:5000 dilution; phospho-CREB, Abcam,
ab32096, 1:5000 dilution; CREB, Cell Signaling Tech-
nology, 9197, 1:1000 dilution) at 4 °C overnight. Mem-
branes were then incubated with peroxidase-conjugated
secondary antibody for 1 h; detection was performed
using West Pico PLUS chemiluminescent substrate
(ThermoFisher Scientiﬁc) and scanned with an Amer-
sham Image 600 imager. Densitometry analysis was
done with ImageJ.
Statistics
All values were expressed as mean ± SEM unless
otherwise noted. Statistical analysis was performed using
t-test if only two conditions. P-value less than 0.05 was
considered statistically signiﬁcant. Each experiment
included at least three replicates per condition. All sta-
tistical analysis was performed using GraphPad Prism
(GraphPad, La Jolla, CA).
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